ShravaniMikkilineniMD

Oculo-Plastic & Orbital Reconstructive Surgery

Physician

Dr. Mikkilineni is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
29201 Telegraph Rd
Suite 324
Southfield, MI 48034
Phone+1 248-357-5100

Oregon Health and Science UniversityOphthalmic Plastic and Reconstructive Surgery Fellowship, 2021 - 2023
Henry Ford Health/Henry Ford HospitalResidency, Ophthalmology, 2017 - 2021
University of Michigan Ross School of BusinessMBA, 2015 - 2017
University of Michigan Medical SchoolClass of 2016

PubMed

319 citations
Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1.
Evangelos Kiskinis, Jackson Sandoe, Luis A. Williams, Gabriella L. Boulting, Rob Moccia
Cell Stem Cell. 2014-06-05
12 citations
Geographic and Demographic Variation in Use of Ranibizumab Versus Bevacizumab for Neovascular Age-related Macular Degeneration in the United States
Emily W. Gower, Joshua D. Stein, Nakul Shekhawat, Shravani Mikkilineni, Taylor Blachley
American Journal of Ophthalmology. 2017-12-01
6 citations
Ciliochoroidal effusion syndrome with central serous-like chorioretinopathy and secondary angle closure following exogenous testosterone use.
Daniel Brill, Desiree C Albert, Taylor Fields, Shravani Mikkilineni, David A. Crandall
American Journal of Ophthalmology Case Reports. 2019-06-05

Third Annual Research Scholar Honoree Program Draws Global InterestFebruary 1st, 2020
Ophthalmology Times® Announces Winners of 3rd Annual Research Scholar Honoree ProgramOctober 30th, 2019